Image not available in RecallScope.
Dantrium intravenous (dantrolene sodium for injection): presence of particulate matter
Official notice
19 Oct 2026
Last checked
13 Nov 2026
An official Health Canada notice concerns Dantrium intravenous (dantrolene sodium for injection): presence of particulate matter. Presence of particulate matter in affected lots. Published 2026-10-19.
What to do now
Consult your healthcare provider for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Recall number
82808
Official notice
2026-10-19
The hazard
The hazard
Presence of particulate matter in affected lots.
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Lots
Other
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: Knight Therapeutics. Contact: the recalling firm if you have any questions about the recall.
Source & status
Source & status
Recall details
Recall details
Recall number
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.